# Aspire BioPharma Inc. — Form C-AR (Regulation Crowdfunding)

Aspire BioPharma Inc. of Humacao, PR filed a Form C-AR (Regulation Crowdfunding) with the SEC on 2024-04-26.

## Offering

- Filed: 2024-04-26
- Form: C-AR
- Accession: 0001493152-24-016259

## Issuer

- CIK: 0001995528
- Website: https://aspirebiolabs.com
- Legal status: Corporation
- Organized in: PR
- Incorporated: 2021-09-27
- Address: 194 Candelaro Drive, Humacao, PR, 00791
- Employees: 0

## Financials (as filed)

- Total assets (most recent): $5.0M
- Cash (most recent): $11K
- Net income (most recent): $-359K
- Net income (prior): $-597K
- Short-term debt: $652K
- Long-term debt: $3.9M

## People (3)

| Name | Role | Location |
| --- | --- | --- |
| Stephen Quesenberry | General Counsel and Corporate Secretary | salem, UT |
| Ernest J. Scheidemann | Chief Financial Officer | Humacao, PR |
| Kraig T. Higginson | Chief Executive Officer & Chairman of the Board | Humacao, PR |

## Reg CF filing history (3)

| Filed | Form | Target | Max |
| --- | --- | --- | --- |
| [2024-02-07](https://search.stillhousedata.com/formc/0001992696-24-000002) | C-U | $150K | $5.0M |
| [2023-10-31](https://search.stillhousedata.com/formc/0001995528-23-000001) | C | $150K | $5.0M |

## More

- [CIK 1995528 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1995528&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formc/0001493152-24-016259.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.